Putnam Investments’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-64,044
| Closed | -$1.97M | – | 1151 |
|
|
2022
Q3 | $1.97M | Sell |
64,044
-232
| -0.4% | -$7.12K | ﹤0.01% | 731 |
|
|
2022
Q2 | $1.89M | Buy |
64,276
+333
| +0.5% | +$9.8K | ﹤0.01% | 756 |
|
|
2022
Q1 | $2.06M | Sell |
63,943
-12,917
| -17% | -$416K | ﹤0.01% | 793 |
|
|
2021
Q4 | $3.43M | Buy |
76,860
+5,159
| +7% | +$230K | ﹤0.01% | 654 |
|
|
2021
Q3 | $3.62M | Sell |
71,701
-17
| -0% | -$858 | 0.01% | 629 |
|
|
2021
Q2 | $5.63M | Buy |
71,718
+98
| +0.1% | +$7.69K | 0.01% | 490 |
|
|
2021
Q1 | $4.09M | Buy |
71,620
+25,538
| +55% | +$1.46M | 0.01% | 542 |
|
|
2020
Q4 | $3.86M | Buy |
+46,082
| New | +$3.86M | 0.01% | 539 |
|